Cargando…

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context

Detalles Bibliográficos
Autores principales: McMurray, John J V, Solomon, Scott D, Docherty, Kieran F, Jhund, Pardeep S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014512/
https://www.ncbi.nlm.nih.gov/pubmed/31898736
http://dx.doi.org/10.1093/eurheartj/ehz916
_version_ 1783673563058798592
author McMurray, John J V
Solomon, Scott D
Docherty, Kieran F
Jhund, Pardeep S
author_facet McMurray, John J V
Solomon, Scott D
Docherty, Kieran F
Jhund, Pardeep S
author_sort McMurray, John J V
collection PubMed
description
format Online
Article
Text
id pubmed-8014512
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80145122021-04-07 The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context McMurray, John J V Solomon, Scott D Docherty, Kieran F Jhund, Pardeep S Eur Heart J Viewpoint Oxford University Press 2020-05-07 /pmc/articles/PMC8014512/ /pubmed/31898736 http://dx.doi.org/10.1093/eurheartj/ehz916 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Viewpoint
McMurray, John J V
Solomon, Scott D
Docherty, Kieran F
Jhund, Pardeep S
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
title The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
title_full The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
title_fullStr The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
title_full_unstemmed The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
title_short The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
title_sort dapagliflozin and prevention of adverse outcomes in heart failure trial (dapa-hf) in context
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014512/
https://www.ncbi.nlm.nih.gov/pubmed/31898736
http://dx.doi.org/10.1093/eurheartj/ehz916
work_keys_str_mv AT mcmurrayjohnjv thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext
AT solomonscottd thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext
AT dochertykieranf thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext
AT jhundpardeeps thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext
AT mcmurrayjohnjv dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext
AT solomonscottd dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext
AT dochertykieranf dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext
AT jhundpardeeps dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext